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Abstract: 
BACKGROUND: Adjustment to living with an implantable cardioverter defibrillator (ICD) is a 
dynamic process that varies among individuals. The purpose of this study was to describe 
patterns of recovery and to examine the relationships among demographic and clinical factors, 
illness appraisal and coping behaviors, and outcomes of physical and emotional function in the 
early recovery period of the first 3 months after initial ICD insertion. 
METHODS: Data were collected in the acute care setting and again at 1 and 3 months after ICD 
insertion. Subjects were 213 patients (83% men), ages 24-85 (mean 59.6) years. Demographic 
and clinical variables representing personal and situational factors, illness appraisal, and coping 
variables were examined using hierarchical multiple-regression analyses to predict outcomes of 
mood disturbance and functional status. 
RESULTS: The data revealed that symptoms, illness appraisal, and coping behaviors 
significantly explained additional variance in both functional status and mood disturbance above 
that accounted for by the less modifiable demographic and clinical variables. 
CONCLUSIONS: Symptoms, illness appraisal, and coping behaviors were predictors of 
outcomes in ICD patients. These factors are modifiable aspects of the recovery process, and 
interventions aimed at symptom management, appraisal reframing, and coping training should be 
tested to improve mood and functional outcomes for ICD patients.  
 
Article: 
With more than 300,000 persons in the United States experiencing sudden cardiac arrest (SCA) 
annually,
1,2
 and more than 100,000 annual hospital admissions for the management of recurrent 
ventrlcular tachycardia,
3
 the implantable cardioverter defibrlllator (ICD) has gained prominence 
in treating high-risk patients. Data from clinical trials in the last decade have caused ICDs to 
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become a widespread mode of treatment with applications to a broader range of patients.4-7 The 
5-year recurrence rate of SCA is about 50% with drug therapy, compared with less than 5% 




The recovery process and the patient’s adjustment to living with an ICD are dynamic processes 
that vary for individual patients. Although studies on the quality of life and psychosocial aspects 
of ICD treatment indicate fairly high acceptance of the device by patients and families, 10-13 
varying degrees of psychological distress and psychiatric disorders in 15-50% of study 
populations have been reported, including such responses as anxl- 
 
ety, anger, depression, and withdrawal. 
14-18
 Feelings of vulnerability, 10, 18-²0 lifestyle changes 
such as restricted driving,²1 and experiences related to device discharge²²,²3 contribute to these 
responses. A better understanding of factors that influence physical and emotional outcomes in 
the early recovery periods would inform the design of programs of care to facilitate adjustment. 
 
Thus, the purposes of this study were (l) to describe patterns of recovery in terms of appraisal- 
coping processes and outcomes of emotional status (mood disturbance) and functional status in 
the first 3 months after ICD implant and (2) to examine factors related to outcomes of emotional 
and functional status in the first 3 months after ICD implant. 
 
The study was based on the Lazarus Stress and Coping Framework,
²4
 which suggests that 
appraised meaning of a stressor and concomitant coping behaviors contribute to outcomes. Indi-
vidual stressors are appraised as a challenge, as a threat, or as benign or harmless. Coping behav-
iors are the cognitive and behavioral efforts exerted to manage the stressful encounter. These 
behaviors serve to decrease the emotional response (through emotion-focused behaviors) or 
resolve issues and address aspects of the stressful situation (through problem-focused behav-
iors).
²4
 Both types of coping are used interchangeably; however, there is some evidence that 




The framework also notes that the individual’s personal characteristics and the nature of the situ-
ation (or context) in which the stressful encounter occurs are important factors in determining the 
appraised meaning of the stressful encounter. For example, several studies reported that the 
personal characteristic of dispositional optimism, or the tendency to view situations with 
optimism, resulted in more positive recovery outcomes from cardiac surgery.
²7,²8
 Situational 
variables for the ICD patient include other illness experiences such as concomitant illnesses 
(comorbidities). After insertion of the device, ICD activation may also become part of the 
context or situation in which the stressful encounter and coping process are taking place. 
Personal and situational factors are viewed as less modifiable than the appraisal and coping 
processes of the transactional stress framework. An overview of the appraisal-coping model and 
variables used in this study are presented in Fig 1. 
 
In the model, outcomes of the appraisal and coping process are interrelated and include physical 
and psychosocial functioning and overall health states. The model is not linear, and the outcomes 
ultimately influence the context of the situation in which the stressor is encountered. This is 
especially important in an ongoing dynamic adjustment process such as living with the 
vulnerability caused by ventricular arrhythmia and the experiences of treatment with the ICD. 
We hypothesized that how patients appraised the meaning of the stressor (living with ventricular 
arrhythmia and treatment with the ICD) and their coping behaviors (emotion- focused and 
problem-focused) would be significant predictors of functional status and mood outcomes after 
controlling for selected personal (demographic) and situational (clinical) factors. The model sug-
gests that the higher levels of mood disturbance and lower levels of functional status would be 
predicted by greater threat appraisals, lower challenge appraisal, greater use of emotion-focused 




This study was part of a larger study in which a repeated-measures, iongitudinal design was used 
to follow ICD patient-family dyads from the preoperative period through the first 9 months after 
ICD insertion. This report outlines the results of the patient data from the first 3 months. Data 
were collected before surgery at baseline in the acute care setting and again at 1 and 3 months 
after ICD implantation. 
 
Setting and sample 
Subjects were recruited from 5 hospitals in the Southeast and Midwest. Two hundred thirteen 
patients (77% of those eligible) who met the following criteria were enrolled: initial ICD 
placement, intact cognitive status, absence of history of psychiatric disorder, and ability to read 
and write in English. 
 
Variables and measures 
Demographic variables were age, sex, and the personal characteristic of dispositional optimism 
obtained from the Life Orientation Test (LOT).
²8 The LOT is a 12-item, self-reported measure of 
global optimism with a Likert response format. Previous reports of internal reliability coefficient 
alpha were .76, with support of both convergent and discriminant validity,²8 and, in this study, 
Cronbach’s alpha was .75. 
 
Clinical data were history of SCA, left ventricular ejection fraction (LVEF), New York Heart 
Association (NYHA) classification, and whether the ICD had delivered a shock during the 
recovery time frame of the study. Measures of comorbidity were calculated by using the 
Charlson co-morbidity index (CMI), which was originally developed to quantify risk of death 
from co-morbid diseases for patients admitted to a hospital medical service.²9 In this study, the 
CMI represented the situational variable of concomitant stressors from other illnesses. 
 
Measures of illness appraisal were obtained by using the Threat and Challenge subscales from 
the Meaning in illness Questionnaire (MIQ)30 and the symptom and fear components from the 
ICD Concerns Questionnaire.
31
 The MIQ was developed to elicit concurrent yet independent and 
divergent meaning ascribed to an illness by chronically ill patients. The ICD Patient Concerns 
questionnaire lists physical, psychological, and economic issues, and patients mark the 
questionnaire according to whether they had concerns about each issue. These 2 appraisal 
perspectives represented global as well as specific appraisal of the stress caused by living with an 
ICD. Coping was measured by using the Jalowiec Coping Scale (JCS),3²,33 and subjects were 
asked to rate frequency of their use of 60 coping behaviors to deal with the stressor of “living 
with an abnormal heart rhythm and its treatment with an ICD.” In order to examine coping 
behavior in accordance with the theoretical model, the instrument was scored into emotion-
focused coping (EFC) and problem-focused coping (PFC) subscales based on categorization of 
the behaviors by a panel of experts.34 Internal consistency was present in the form of Cronbach’s 
alpha coefficients of .90 and .91 for the emotion-focused and problem- focused subscales 
respectively. 
 
Emotional outcome was measured by the total mood disturbance (TMD) score on the Profile of 
Mood States (POMS) .35 Total mood disturbance represents the emotional state of an individual, 
when that state is transient and responsive to the environment or interventions rather than an 
enduring personality trait.
36
 The POMS includes 65 adjectives that subjects rate on a 5-point 
scale according to how well the adjective describes their feelings during the past week, including 
the day the test is administered. Six emotional dimensions: tension- anxiety, depression-
dejection, anger-hostility, vigor- activity, fatigue-inertia, and confusion-bewilderment, are 
measured. A TMD score is obtained by adding the 6 primary mood scores (with vigor weighted 
negatively). internal consistency for the scales ranged from .84 to .97 in the ICD population.37 
 
Functional status, defined as the patient’s perception of his or her physical ability in relationship 
to the cardiac illness, was measured by the Heart Failure Functional Status Inventory (HFFSI), 
which was adapted from a standardized functional status measure and revised for patients with 
cardiac disease with low LVEF by Dracup and colleagues.
38 This instrument was selected for its 
applicability to the ICD patient population, which tends to have compromised left ventricular 
function. The HFFSI lists 12 specific physical activities, and subjects rate the degree to which 
they can perform each activity. Subjects also rate any limiting symptoms. 
 
The HFFSI is scored by averaging the 3 highest metabolic equivalents (METs) assigned to the 
activities. Content validity of the tool was established by a panel of judges in the field of 
cardiology, and interrater reliability in assigning MET level to activity was confirmed.38 In this 
study the MET level (METLEV) was used as the dependent measure of functional status for 
hypotheses testing. In the ICD population, the HFFSI had a Cronbach’s alpha of .86, and 





Separate, audiotaped, semistructured telephone interviews regarding experiences during the 
recovery process were conducted with patients at 1 and 3 months. The interview questions were 
structured to elicit patients’ perceptions of experiences, as well as their perceptions of what was 
most helpful in coping with their concerns. Content analysis of interview data was performed to 
identify themes, which were coded by using Ethnograph .40 Coding was initially performed by 2 
raters, and interrater reliability was established and verified. The interview data were used to 
clarify the quantitative data obtained from the ICD concerns and coping instruments. 
 
Procedure 
The Short Portable Mental Status Questionnaire (SPMSQ)41 was used to determine cognitive 
eligibility to give informed consent and participate in the study. The SPMSQ measures 
orientation, remote memory, and ability to perform mental functions with reported test-retest 
reliability at .83; concurrent criterion-related validity was established by comparing the patient’s 
mental status clinical assessment and the SPMSQ.41 Nine percent of those screened were 
excluded because of cognitive difficulties. After written informed consent to participate 
according to the policies of the Institutional Review board of Emory University, clinical and 
demographic data were obtained, and a battery of questionnaires (POMS, JCS, MIQ, LOT, 
HFFSI, ICD Concerns) was completed before ICD implantation. For a small percentage (7%) 
whose ICD procedure was scheduled more imminently, the battery of questionnaires was 
completed as soon as possible after implantation, at a time after recovery from sedation. At 1 and 
3 months, questionnaires (minus the LOT) were mailed to subjects with a stamped, return-
addressed envelope. After receipt of the completed 1-month and 3- month questionnaires, the 
telephone interviews were conducted. Chart reviews were performed to examine medication 
changes and device therapy over the 3 months. 
 
Because subjects were recruited from 5 hospitals, patient education standards for ICD care from 
each site were reviewed to determine whether there were differences in practice patterns. 
Although there was variation in the actual printed materials and videotapes used for patient 




Before addressing the research questions, demographic and outcome data were compared by 
enrolling sites, and no differences on predictor variables by site were found. Changes in medica-
tions noted from the chart reviews were examined. This review revealed no changes or 
introduction of medications, such as anti-anxiety or antidepressant drugs, which would 
potentially influence the outcome data. Repeated-measures analyses of variance (ANOVA) were 
performed for each appraisal and coping variable to determine change over time. In addition, 
separate hierarchical multiple- regression equations4² were used to determine the amount of the 
variance that could be accounted for in the outcome variables of mood disturbance (TMD) and 
functional status (METLEV). Hierarchical regression models were used to control the effects of 
the personal or situational factors or both so that the unique predictive power of the appraisal and 
coping variables could be evaluated. The order of entry of variables was determined by the 
concepts of the theoretical model. The pre- stressor variables representing personal and situa-
tional variables were entered first on step l, followed by the appraisal and coping variables on 
step ll. In other words, challenge and threat appraisal scores, symptoms, fear, problem-focused 
coping, and emotion-focused coping scores were 
 
the predictor variables entered in step ll, aiong with age, sex, LOT score, LVEF, NYHA, 
Charlson CMI score, history of SCA, and number of ICD shocks (personal and situational 
variables) entered first as a block to control for the effects of these variables. Because of the 
theoretical and 
 
clinical relationship between mood and functional status outcomes and their reciprocal influence 
on the context of the stress-coping process, METLEV was also used as a situational variable 
when predicting TMD, and, vice versa, TMD was used as a situational variable when predicting 
METLEV. Evaluation of the data and regression diagnostics suggested that the appropriate 
statistical assumptions for the hierarchical multiple-regression procedures were met. 
 
Findings 
Characteristics of the total ICD patient sample (Table l) included mean age of 59.59 ± 13% 
(range 24 to 85) years, with 83% men and 17% women. The majority of the subjects were 
married and retired, and the sample represented a fairly well educated group. Mean LVEF was 
32.3% ± 13, representing fairly compromised cardiac function. Approximately 23% of the 
subjects had experienced SCA. The majority had transvenous lead placement, with pectoral site 
for ICD implant used in 40% of subjects. Attrition from the study was 16%, with withdrawals 
because of the death of subjects (n = 10), subjects’ deteriorating physical or mental health or 
both, or subjects’ deteriorating cognitive status (n = 17). Loss to follow up (n = 7) because of 
rehospitalization at time of data collection resulted in missing data on selected instruments at 
various time points; therefore, the numbers of subjects in the various statistical analysis varied 
slightly. 
 
Separate repeated-measures (ANOVA) across time showed significant change for all appraisal, 
coping, and outcome variables, except challenge appraisal (Table ll). All values were highest at 
entry, the time surrounding ICD implantation. TMD scores decreased slightly, but significantly, 
from entry to 1 month, with no change from 1 to 3 months. Analysis of the subscales of the 
POMS revealed that initial declines in TMD scores were primarily due to decreases in the 
subscale of confusion, and slight increases in vigor. Tension/anxiety and depression subscale 
scores showed little change. Although mean length of hospital stay (LOS) changed from 10.7 
days at the beginning to 3.5 days during the third year of data collection, outcome measures of 
TMD and METLEV did not vary by LOS or surgical approach, suggesting that emotional 
responses persisted even though surgical procedures and devices became less invasive. Similar to 
TMD, threat appraisal scores showed little decline after the 1-month time point. 
 
The most frequently reported concerns from the ICD Concerns Asssessment are reported in 
Table lll. Concerns about tiredness, shortness of breath, reduced sexual activity, and sleep 
disturbances 
 
(both initiating and maintaining sleep) persisted across time. Symptoms of fast pulse and 
dizziness, reported by at least two thirds of the subjects at entry, were not reported as concerns in 
the 1- month and 3-month periods. 
 
The results of the hierarchical multiple-regression analysis performed by regressing the TMD 
score on personal-situational variables and appraisal-coping variables at entry, 1 month, and 3 
months revealed different predictors at the 3 time points. At entry, 54% of the variance (adjusted 
R²) in TMD could be accounted for by the model with independent predictors of LOT, sex, 
number of concerns about symptoms, fear, threat appraisal, higher use of EFC and lower use of 
PFC. At 1 month, 55% of the variance was accounted for with the following independent 
predictors of TMD scores: history of SCA, lower METLEV, greater number of concerns about 
symptoms, higher fear, lower challenge appraisal, and greater use of EFC (Table lV). The 
direction of the relationship of SCA and TMD suggests that subjects who had experienced SCA 
had 
 
lower TMD at 1 month than those who had not. At 3 months, 49% of the variance in TMD was 
accounted for with LOT, METLEV, concerns about symptoms, threat and challenge appraisal, 
and greater EFC as independent predictors (Table V). By testing separate hypotheses for 
preoperative and postimpiantation period, the contributions of the variables at different times in 
the encounter of the stressor (ICD) were clarified. Fig 2 reflects the total variance in TMD 
accounted for at each time point and designates the proportion associated with the blocks of 
personal/situational and coping/appraisal variables. 
 
At entry, the predictors of functional status accounted for 28% of the variance, with sex, LVEF, 
CMI, and number of concerns about symptoms as the independent predictors. At 1 month, 33% 
of the variance was accounted for by sex, TMD, comorbidity index, threat appraisal, and 
problem-focused coping as predictors (Table Vl). At 3 months, 36% of the variance was 
accounted for by sex, TMD, CMI, and number of concerns about symptoms as predictors (Table 
Vll). 
 
To better understand the outcomes given the wide range of 1-month and 3-month TMD scores (-
32 to 138 and -32 to 135, respectively), subjects were divided into quartiles based on TMD 
scores, and content analysis of the interview data from subjects in the highest and lowest 
quartiles were examined. At 1 month, themes from the highest mood disturbance quartile 
differed from the lowest respectively on reporting device shocks (40% vs no shocks), 
rehospitalizations (36% vs none), complications related to heart rhythm or device activity or both 
(12% vs none), sleep disturbances (60% vs 26%), incisional and device pain (53% vs 10.5%), 
and heightened awareness of the device (52% vs 31.6%). At 3 months, subjects in the highest 
TMD quartile had experienced greater use of health services for the following reasons: ICD 
shocks, ICD complications such as infection or lead problems, physiologic symptoms such as 
pain, and rehospitalization. In the group with higher TMD, interviews showed a greater number 
of reported themes about sleep disturbances than the low-TMD group (42.9% vs 26.3%). The 
same trend was found with reporting of low activity levels (25% in high TMD group vs 15.8% in 
the low TMD group). Twenty-one percent of the high-TMD group vs only 1 person in the low-
TMD group had received 1 or more ICD shocks at 3 months. 
 
DISCUSSION 
Patterns of recovery 
The scores on the appraisal-coping variables and outcome measures reveal that patterns of 
recovery after ICD vary over time and are quite diverse for individuals. The TMD scores were 
highest before implantation, suggesting that this is a vulnerable time characterized by high levels 
of anxiety and confusion. Although mean TMD scores dropped significantly by 1 month, the 
range or variability remained high, suggesting that a cohort of patients may require targeted 
intervention. TMD and illness appraisal scores in terms of perceived threat and challenge 
remained stable between 1 and 3 months, suggesting that without targeted activities to improve 
mood states, adjustment did not continue beyond this early time frame. 
 
The persistence of symptoms is important in the recovery process for ICD patients in that 
symptoms influence appraisals by reminding patients of cardiac impairment and perpetuating 
concerns about health.43 The proportion of patients reporting tiredness and shortness of breath 
and the persistence of these symptoms across the early recovery period are likely caused by the 
low cardiac function and low LVEF in this sample. These data of low LVEF and low overall 
functional status were consistent with clinical characteristics of other ICD outcome studies.
44,45
 
Sleep difficulties in terms of both initiating and maintaining sleep are prime areas for targeted 
intervention, and successful approaches may also influence the concerns about tiredness. Many 
causes of sleep disturbance are amenable to intervention. 
 
Predictors of TMD 
Hierarchical multiple-regression analyses revealed that the appraisal-coping variables accounted 
for significant increases in the amount of variance accounted for in TMD over that accounted for 
by the personal-situational variables at each time point in the early recovery process. In the total 
models, dispositional optimism was important at entry and 3 months, and functional status was 
an important factor in both postimplant time frames. Patients who had experienced SCA actually 
had lower TMD at 1 month. Content analysis of the interview data helped explain this finding 
and suggested that the ICD provided a sense of security for this group whereas many who had 
not experienced SCA questioned the need for the device. Activation of the ICD did not prove to 
be a statistically significant predictor of mood or functional status; however, those who had 
experienced ICD activations discussed these experiences as important themes in the interviews 
from the high-TMD quartile. Several interesting patterns emerged with regard to ability of the 
appraisal and coping variables to predict TMD. Noteworthy is the role of greater number of 
concerns about symptoms and fear at entry and 1 month. Threat appraisal was an independent 
predictor at entry and again at 3 months, whereas challenge was significant in the postrecovery 
period only. These cognitive appraisals reflect an ongoing interpretation of the ventricular 
arrhythmia and ICD experience as characterzied by seriousness, uncontrollability, and fear, with 
potentially disabling or disfiguring consequences or both. Most important, the impact of these 
combined appraisals is greater mood disturbance. In other chronically ill patients, appraisal of 
illness as a harm or threat coupled with low challenge appraisal explained a significant amount 
of variance in poor adjustment.
30
 In patients who have had myocardial infarctions, threat 
appraisal has been related to negative emotional outcomes.
46
 Cognitive appraisal, or interpre- 
 
 
tation of the meaning of the ICD is a prime area for developing interventions aimed at providing 
patients with a greater sense of control and reducing symptoms and fear. 
 
Higher levels of emotion-focused coping predicted TMD at all time points, with problem- 
focused coping associated with lower TMD at entry and 3 months. These data are similar to the 
findings of Craney et al
45
 and to our preliminary report of entry data from the first 100 patients, 
in which a reduced model for analysis was used.37 In our preliminary report we suggested that 
evasive coping (EFC) was not effective in the acute care setting because of the overwhelming 
illness-related cues and patient education; however, data from this analysis suggest that EFC is 
less effective in the outpatient setting as well. Although EFC is theorized to reduce the negative 
emotional response to 
 
a stressor, in the ICD population EFC appears to jeopardize recovery by promoting avoidance in 
the context of intense symptoms.²4 More active, problem-focused coping in the form of seeking 
information and the support of others may in fact be more important in reducing feelings of 
helplessness and anxiety when confronted with novel and highly somatic illness situations, such 
as ICD implantations. The quantitative data of symptoms as predictors of TMD triangulated with 
the interview data reflecting themes of device awareness and symptoms emphasize the 
importance of the role of psychophysiologic symptom awareness in ICD patient recovery. 
 
Predictors of functional status 
At entry, the personal-situational variables of sex, ejection fraction, and comorbidity were 
significant predictors of functional status, with number of symptoms adding a small amount to 
the variance. The 1-month and 3-month regression analyses for functional status were deemed as 
more important because the entry level is not amenable to modification given the short lengths of 
stay. Being female remained a significant predictor of lower functional level across the 3-month 
recovery period, even though women did not have lower LVEF or greater CMI. Craney et al45 
reported that men and less emotional ICD subjects were more physically active at the time frame 
of 2 years or more after implant. The role of TMD and sex as significant predictors of lower 
functional status in the 1-month and 3-month recovery time frame reflects the important 
influence of these variables early in the recovery process. These data emphasize the 
interrelationship of physical and emotional outcomes and underscore the importance of 
emotional recovery. Aspects of the appraisal process, specifically threat and number of concerns 
about symptoms, were significant predictors of functional status at 1 and 3 months respectively. 
Contrary to findings by Craney et al
45
 of reduced physical functioning related to higher emotion-
focused behavior at 2 years, emotion-focused coping was not related to functional status in our 
sample. However, problem-focused coping was a significant predictor at 1 month, indicating that 
those with greater use of problem-focused coping behaviors had higher functional status. 
Although less variance in functional status was predicted by the model than was predicted for 
TMD, the influence of appraisal and the mood state on functional status warrants further 
attention in this patient population. Interventions addressing the cognitive appraisal-coping 
process should be tested for their effects on physical functioning as well as emotional outcomes 
in ICD patients. These data could be used to design interventions to reduce symptom distress and 
improve functional ability, which in turn may improve symptom presentation and mood. 
 
Conclusions 
These findings suggest that candidates for ICD insertion bring certain personality factors, 
appraisal, and coping behaviors to the implant situation that should be further examined in 
relationship to subsequent recovery outcomes. Underlying cardiac function is an important factor 
in the overall recovery trajectory and symptom presentation of patients with ICDs and should be 
considered when examining outcomes. The appraisal and coping variables, which are modifiable 
aspects of the adaptation process, accounted for significant increases in the adjusted R² over the 
personal-situational variables at each time point. The interrelationship of the mood and 
functional status outcomes gives support to the nonlinear nature of the stress-coping process. The 
patterns of change in the appraisal-coping variables and outcomes suggest that the early recovery 
time frame of the first 3 months is important for targeted intervention. By targeting interventions 
for patients at higher risk for less adaptive recovery, nursing and health provider efforts may be 
used more efficiently and for those in greatest need. These findings provide direction for the 
development and testing of interventions aimed at symptom management, appraisal, reframing, 
and coping skills training to improve recovery outcomes for ICD patients. 
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